BioMedomics Won First Place at the RESI Boston 2016 Innovation Challenge!
To view the full list of winners, please click here
BioMedomics is pleased to announce that we were selected from 30 highly innovative start-up companies as the First Place Winner for the RESI Boston 2016 Innovation Challenge! We are honored to receive this recognition of our expert team and the vast potential of our products.
BioMedomics presented its innovative rapid point-of-care diagnostics line, which provides unprecedented ease of use, efficiency and accuracy for the diagnosis of lethal and widespread hemoglobin disorders. These tests are CE Mark approved, and are currently sold in countries around the globe.
Additionally, BioMedomics presented the research and development progress of next generation devices based upon the company’s patented time-resolved lateral flow immunoassay platform. This advanced diagnostic platform is capable of detecting biomarkers at picogram-levels, comparable to the sensitivity of large scale laboratory equipment.
To learn more about the RESI Innovation Challenge and view the full list of winners, please click here
To learn more about our products please click here